Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

CiRA Builds iPS Cell Stock, Targets 30% Coverage for Japan’s Population

Filed Under: Innovation, Pharma Tagged With: , ,

The Center for iPS Cell Research and Application (CiRA) at Kyoto University expects to expand its stock of induced pluripotent…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Asahi Kasei Works on New iPS Treatments for Orthopedic Sector
Asahi Kasei Works on New iPS Treatments for Orthopedic…
Keio University Venture Looks to Achieve Breakthrough in Cardiovascular Regenerative Medicine
Keio University Venture Looks to Achieve Breakthrough in…
Nissan Chemical Eyes Global Expansion of High-Performance, Cost-Effective Cell Culture Supplement
Nissan Chemical Eyes Global Expansion of High-Performance,…
Kyoto University Venture Thyas Uses iPS Cells to Generate Killer T Cells for Cancer Treatment
Kyoto University Venture Thyas Uses iPS Cells to Generate…
Tosoh Enables Simple Removal of Regenerative Medicine Cells Using New Thermoresponsive Polymer
Tosoh Enables Simple Removal of Regenerative Medicine Cells…
Sekisui Chemical Moves Into Cell Culture Sector
Sekisui Chemical Moves Into Cell Culture Sector